MedTrace Logo

Exparel vs Exparel Plus ACB in TKAs

NCT02365727 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2016-01-14

No results posted yet for this study

Summary

Patients will be randomized (like the flip of a coin) to receive Exparel and a nerve block, standard of care for this procedure, or Exparel alone for pain management after surgery. They will also be asked to complete questionnaires before surgery, during their stay at the hospital after surgery, then at 3 months, 6 months and 12 months after surgery to assess pain and/or function levels, as well as the amount of pain medicine patients have used after surgery. Patients' leg strength will be measured immediately after surgery and again at 3, 6 and 12 months after surgery.

Conditions

Interventions

DRUG

Liposomal bupivacaine

DRUG

Ropivacaine

DRUG

Epinephrine

DRUG

Clonidine

DRUG

Saline

Sponsors & Collaborators

  • The Hawkins Foundation

    lead OTHER

Principal Investigators

  • Brayton Shirley · Steadman Hawkins Clinic of the Carolinas - Greenville Health System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02365727 on ClinicalTrials.gov